Image: Dr. Christopher Mason https://news.weill.cornell.edu/news/2019/04/astronaut-twins-study-yields-new-insights-algorithms-and-portable-dna-sequencing-tools
Home » Health and medicine » COVID-19 Town Hall on environmental sampling for coronavirus

COVID-19 Town Hall on environmental sampling for coronavirus

Weill Cornell Medicine professor Christopher Mason has swabbed the NYC subway system before with surprising results. Now, with help from Twist Bioscience’s NGS Target Enrichment tools for Coronavirus, Chris is sampling the public transit system to see if and where the novel coronavirus is residing. Chris will be in conversation with Twist CEO Emily Leproust, as well as Josh Perfetto, founder and CEO of Chai Bio, which makes tools like Open qPCR accessible to researchers everywhere. We will discuss how public swabbing works, and Josh will share results coming out in pre-print in the coming days.

March 27, 2020, 8:00 AM Pacific Time

5
Kevin Costa

Kevin Costa

As Editor and Program Manager, Kevin leads SynBioBeta's digital media content, with the goal of telling the story of the people, companies, and ideas shaping the future with biology. Before joining SynBioBeta, Kevin managed the Synthetic Biology Engineering Research Center. His interests include public engagement, science writing, community building, and bikes!

Marianna Limas

Marianna Limas

Marianna plays a critical role in displaying and communicating SynBioBeta’s message to the world. She manages SynBioBeta’s social media channels and newsletter, and works with the editorial, website, research and marketing teams.

John Cumbers

John Cumbers

John Cumbers is the founder of SynBioBeta. John is passionate about education and on the use and adoption of biological technologies. He has received multiple awards and grants from NASA and the National Academy of Sciences for his work in the field. John has been involved in multiple startups such as those producing food for space, microbes to extract lunar and martian resources, and hoverboards! John is an active investor through the DCVC SynBioBeta Fund and his synthetic biology syndicate on AngelList.

Click here to join our weekly newsletter. We want to hear what you think about this article. Got a tip for our news team? Write to editorial@synbiobeta.com.